119 related articles for article (PubMed ID: 1988897)
21. Midtrimester pregnancy termination by intravaginal administration of prostaglandin E2.
Surrago EJ; Robins J
Contraception; 1982 Sep; 26(3):285-94. PubMed ID: 6756775
[TBL] [Abstract][Full Text] [Related]
22. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy.
Jain JK; Mishell DR
N Engl J Med; 1994 Aug; 331(5):290-3. PubMed ID: 8022438
[TBL] [Abstract][Full Text] [Related]
23. Induction of labor with intravenous oxytocin or vaginal PGE2 suppositories. A randomized study.
Ekman G; Granström L; Ulmsten U
Acta Obstet Gynecol Scand; 1986; 65(8):857-9. PubMed ID: 3548209
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandin E2 vaginal suppository for induction of labour: an efficient, safe and popular method.
Legarth J; Lyndrup J; Dahl C; Philipsen T; Eriksen PS
Eur J Obstet Gynecol Reprod Biol; 1987 Nov; 26(3):233-8. PubMed ID: 3480840
[TBL] [Abstract][Full Text] [Related]
25. Labor characteristics of uncomplicated prolonged pregnancies after induction with intracervical prostaglandin E2 gel versus intravenous oxytocin.
Papageorgiou I; Tsionou C; Minaretzis D; Michalas S; Aravantinos D
Gynecol Obstet Invest; 1992; 34(2):92-6. PubMed ID: 1398272
[TBL] [Abstract][Full Text] [Related]
26. Vaginally administered prostaglandin E2 as a first and second trimester abortifacient.
Corson SL; Bolognese RJ
J Reprod Med; 1975 Feb; 14(2):43-6. PubMed ID: 1113258
[TBL] [Abstract][Full Text] [Related]
27. High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial.
Nuthalapaty FS; Ramsey PS; Biggio JR; Owen J
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1065-70. PubMed ID: 16157113
[TBL] [Abstract][Full Text] [Related]
28. Induced second trimester abortion by extra-amniotic prostaglandin infusion in patients with a cesarean scar: is it safe?
Shapira S; Goldberger S; Beyth Y; Fejgin MD
Acta Obstet Gynecol Scand; 1999 Jul; 78(6):511-4. PubMed ID: 10376860
[TBL] [Abstract][Full Text] [Related]
29. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
Bolognese RJ; Corson SL
Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
[TBL] [Abstract][Full Text] [Related]
30. Comparison between intraamniotic PGF2 alpha and vaginal PGE2 for second-trimester abortion.
Lebed JP; Rubin A; Millman AE
Obstet Gynecol; 1980 Jul; 56(1):90-6. PubMed ID: 7383493
[TBL] [Abstract][Full Text] [Related]
31. Multiple-dose vaginal misoprostol and single-dose misoprostol plus oxytocin for termination of second-trimester pregnancy.
Zangeneh M; Malek-Khosravi S; Veisi F; Rezavand N; Rezaee M; Rajatee M
Int J Gynaecol Obstet; 2012 Apr; 117(1):78-80. PubMed ID: 22261129
[TBL] [Abstract][Full Text] [Related]
32. A comparison of Syntocinon infusion with prostaglandin vaginal pessaries when spontaneous rupture of the membranes occurs without labour after 34 weeks gestation.
Rymer J; Parker A
Aust N Z J Obstet Gynaecol; 1992 Feb; 32(1):22-4. PubMed ID: 1586329
[TBL] [Abstract][Full Text] [Related]
33. Extra-amniotic prostaglandin E2 for midtrimester termination of pregnancy in live fetuses vs. fetal demise.
Debby A; Sagiv R; Girtler O; Sadan O; Glezerman M; Golan A
Arch Gynecol Obstet; 2003 Oct; 268(4):301-3. PubMed ID: 14504874
[TBL] [Abstract][Full Text] [Related]
34. Progesterone inhibition in mid-trimester termination of pregnancy: physiological and clinical effects.
Selinger M; Mackenzie IZ; Gillmer MD; Phipps SL; Ferguson J
Br J Obstet Gynaecol; 1987 Dec; 94(12):1218-22. PubMed ID: 3322376
[TBL] [Abstract][Full Text] [Related]
35. Comparison of prostaglandin E2 vaginal tablet with amniotomy and intravenous oxytocin for induction of labour.
Lo L; Ho MW; Leung P
Aust N Z J Obstet Gynaecol; 1994 May; 34(2):149-53. PubMed ID: 7980302
[TBL] [Abstract][Full Text] [Related]
36. A comparative randomized study of oral prostaglandin E2 (PGE2) tablets and intravenous oxytocin in induction of labor in patients with premature rupture of membranes before 37 weeks of pregnancy.
el-Qarmalawi AM; Elmardi AA; Saddik M; el-Abdel Hadi F; Shaker SM
Int J Gynaecol Obstet; 1990 Oct; 33(2):115-9. PubMed ID: 1976543
[TBL] [Abstract][Full Text] [Related]
37. Oxytocin versus sustained-release dinoprostone vaginal pessary for labor induction of unfavorable cervix with Bishop score ≥ 4 and ≤ 6: a randomized controlled trial.
Koc O; Duran B; Ozdemirci S; Albayrak M; Koc U
J Obstet Gynaecol Res; 2013 Apr; 39(4):790-8. PubMed ID: 23167718
[TBL] [Abstract][Full Text] [Related]
38. Induction of labor. A double-blind randomized controlled study of prostaglandin E2 vaginal suppositories compared with intranasal oxytocin and with sequential treatment.
Andreasson B; Bock JE; Larsen J
Acta Obstet Gynecol Scand; 1985; 64(2):157-61. PubMed ID: 3885670
[TBL] [Abstract][Full Text] [Related]
39. Extra-amniotic prostaglandin E2 and intravenous oxytocin in termination of mid-trimester pregnancy and the management of missed abortion and hydatiform mole.
Arshat H
Med J Malaysia; 1977 Mar; 31(3):220-5. PubMed ID: 904515
[TBL] [Abstract][Full Text] [Related]
40. A comparison of oral prostaglandin E2 tablets with intravenous oxytocin for stimulation of labor after premature rupture of membranes at term.
Massil HY; Baker AC; O'Brien PM
Acta Obstet Gynecol Scand; 1988; 67(8):703-9. PubMed ID: 3250183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
